Toggle Main Menu Toggle Search

Open Access padlockePrints

The NCRI Myeloma XI trial for newly diagnosed symptomatic multiple myeloma (NDMM); second primary malignancy (SPM) incidence when lenalidomide is used as an induction and maintenance treatment option

Lookup NU author(s): Professor Graham Jackson


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Jones JR, Cairns D, Gregory W, Sigsworth R, Collett C, Pawlyn C, Striha A, Kaiser M, Drayson MT, Davies FE, Boyd K, Owen R, Morgan GJ, Jackson GH

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: XXXVI World Congress of the International Society of Hematology

Year of Conference: 2016

Pages: 86

Print publication date: 01/04/2016

Online publication date: 12/04/2016

Acceptance date: 02/04/2016

ISSN: 0007-1048

Publisher: Wiley-Blackwell


DOI: 10.1111/bjh.14019

Series Title: British Journal of Haematology